Akari Therapeutics Plc Azioni in circolazione
Cos'è Azioni in circolazione di Akari Therapeutics Plc?
Azioni in circolazione di Akari Therapeutics Plc è 12.145M
Qual è la definizione di Azioni in circolazione?
Le azioni in circolazione sono tutte le azioni di una società o di un'attività finanziaria che sono state autorizzate, emesse e acquistate dagli investitori e sono detenute da loro.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Azioni in circolazione di aziende nel Health Care settore su NASDAQ rispetto a Akari Therapeutics Plc
Cosa fa Akari Therapeutics Plc?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Aziende con azioni in circolazione simili a Akari Therapeutics Plc
- Credit Acceptance ha Azioni in circolazione di 12.111M
- Stratec SE ha Azioni in circolazione di 12.128M
- Immunome ha Azioni in circolazione di 12.129M
- Swaraj Engines ha Azioni in circolazione di 12.134M
- Swaraj Engines ha Azioni in circolazione di 12.141M
- Le Tanneur & Cie Societe anonyme ha Azioni in circolazione di 12.144M
- Akari Therapeutics Plc ha Azioni in circolazione di 12.145M
- S&U Plc ha Azioni in circolazione di 12.151M
- John Hancock Hedged equity & Income Fund ha Azioni in circolazione di 12.151M
- Gandhi Special Tubes ha Azioni in circolazione di 12.152M
- Emmis Corp ha Azioni in circolazione di 12.157M
- Prime People Plc ha Azioni in circolazione di 12.157M
- PermRock Royalty Trust ha Azioni in circolazione di 12.166M